Barchart Research What to Expect from SLNO Earnings SLNO Generated May 12, 2026 Current Price $52.93 EPS Estimate $$0.91 Consensus Rating Hold Average Move 7.00% Soleno's First Earnings as a Fifty-Three...
SAN FRANCISCO , May 11, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) of the pending securities class action...
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
Barchart Research What to Expect from SLNO Earnings SLNO Generated May 5, 2026 Current Price $52.92 EPS Estimate $$0.73 Consensus Rating Hold Average Move 7.00% Soleno Therapeutics: The May Fifth Legal...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Soleno To Contact Him Directly To Discuss Their Options
NEW YORK , May 5, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO).
The Law Offices of Frank R. Cruz reminds investors of the upcoming May 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on...
NEW YORK , May 4, 2026 /PRNewswire/ --
LOS ANGELES , May 4, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Soleno Therapeutics, Inc. ("Soleno" or "the Company") (NASDAQ: SLNO ) for violations...
LOS ANGELES , May 4, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Soleno Therapeutics, Inc. ("Soleno"...